Full Text View
Tabular View
No Study Results Posted
Related Studies
Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major
This study has been completed.
First Received: August 3, 2000   Last Updated: June 23, 2005   History of Changes
Sponsors and Collaborators: National Center for Research Resources (NCRR)
Children's Hospital of Philadelphia
Information provided by: Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier: NCT00006138
  Purpose

OBJECTIVES:

I. Determine the frequency and severity of osteopenia and osteoporosis in patients with thalassemia major who undergo dual energy x-ray absorptiometry, and correlate these findings with other relevant endocrinologic measurements.


Condition
Osteoporosis
Thalassemia Major
Osteopenia

Study Type: Observational
Study Design: Screening

Resource links provided by NLM:


Further study details as provided by Office of Rare Diseases (ORD):

Estimated Enrollment: 35
Study Start Date: June 1998
Estimated Study Completion Date: August 2000
Detailed Description:

PROTOCOL OUTLINE:

Patients undergo dual energy x-ray absorptiometry for bone density measurements, height (sitting and standing) and weight measurements, comprehensive endocrinologic examination, and assessment of the severity of iron overload at baseline, and then at years 1 and 2.

  Eligibility

Ages Eligible for Study:   6 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Diagnosis of thalassemia major with iron overload
  • Not pregnant
  • Negative pregnancy test
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00006138

Sponsors and Collaborators
Children's Hospital of Philadelphia
Investigators
Study Chair: Alan Richard Cohen Children's Hospital of Philadelphia
  More Information

No publications provided

Study ID Numbers: 199/15314, CHP-IRB-1998-6-1502, CHP-GCRC-1655
Study First Received: August 3, 2000
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00006138     History of Changes
Health Authority: United States: Federal Government

Keywords provided by Office of Rare Diseases (ORD):
disease-related problem/condition
genetic diseases and dysmorphic syndromes
hematologic disorders
osteoporosis
rare disease
thalassemia major

Study placed in the following topic categories:
Hematologic Diseases
Beta-thalassemia
Rare Diseases
Anemia
Osteoporosis
Anemia, Hemolytic
Bone Diseases, Metabolic
Thalassemia
Bone Diseases
Anemia, Hemolytic, Congenital
Thalassemia Minor
Genetic Diseases, Inborn
Musculoskeletal Diseases
Beta-Thalassemia
Hemoglobinopathies
Hemoglobinopathy

Additional relevant MeSH terms:
Anemia, Hemolytic, Congenital
Musculoskeletal Diseases
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Beta-Thalassemia
Anemia
Anemia, Hemolytic
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Thalassemia

ClinicalTrials.gov processed this record on July 02, 2009